Share Prices & Company Research

Market News

13 Mar 2019 | 14:35

EKF Diagnostics profit jumps on Renalytix AI spin-off gain

Point-of-care group EKF Diagnostics Holdings posted a large rise in annual profit after it booked a gain on the spin-off of its biomarker unit Renalytix AI.

Pre-tax profit for the year through December rose to £12.2m, up from £4.3m on-year.

Revenue rose 2% to £42.5m, while gross profit fell slightly to £22.7m.

'This has been a very successful year, which has allowed us to provide significant rewards for shareholders,' chief executive Christopher Mills said.

'We are confident that we will continue to make progress in 2019.'

'Trading in the first quarter to date has been satisfactory, in line with management expectation.'

At 2:35pm: (LON:EKF) EKF Diagnostics Holdings PLC share price was -1.15p at 30.55p

Story provided by
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.